Labcorp Holdings Inc. LH
309.64
0.69
0.22%
as of 25 Sep
- Market cap
- $21.9B
- P/E
- 25.4×
Follow LH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Labcorp Holdings Inc. (LH) P/E ratio
As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a P/E ratio of 25.4×. Over the past ten years it has ranged from 7.4× (December 2018) to 49.5× (January 2024); the current reading is higher than 75% of that period. That is below the Diagnostics & Research industry median of 33.9× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 23.8× | (7.72%) |
| FY2024 | 25.8× | (47.87%) |
| FY2023 | 49.5× | 237.41% |
| FY2022 | 14.7× | 33.53% |
| FY2021 | 11.0× | 0.17% |
| FY2020 | 11.0× | (36.48%) |
| FY2019 | 17.3× | 38.49% |
| FY2018 | 12.5× | 10.76% |
| FY2017 | 11.3× | (28.45%) |
| FY2016 | 15.7× | (35.64%) |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 23.0× | (2.04%) |
| Mar 2026 | 23.5× | (1.33%) |
| Dec 2025 | 23.8× | (14.93%) |
| Sep 2025 | 28.0× | (2.58%) |
| 42 more quarters | Free account |
Against its own ten years
Low 7.4×
High 49.5×
Ten-year median
18.5×
Current reading's percentile
75
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CRL Charles River Laboratories International, Inc. compare | n/m |
| GH Guardant Health, Inc. compare | n/m |
| TWST Twist Bioscience Corporation compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 24.8× |
| LH Labcorp Holdings Inc. | 25.4× |
| MTD Mettler-Toledo International, Inc. compare | 33.9× |
| MEDP Medpace Holdings, Inc. compare | 35.6× |
| RVTY Revvity Inc. compare | 72.0× |
| ICLR ICON PLC compare | 257× |
| Diagnostics & Research industry median | 33.9× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on LH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement